Metabolomic screening and urolithins metabotypes identification in the urinary metabolome of Costa Rican volunteers after blackberry ( Rubus adenotrichos )-based drink consumption
Restricted accessResearch articleFirst published online September 2, 2024
Metabolomic screening and urolithins metabotypes identification in the urinary metabolome of Costa Rican volunteers after blackberry ( Rubus adenotrichos )-based drink consumption
Besides providing nutritional value, functional foods have potential beneficial effects on health. Consumers worldwide seek food products with added value based on physical and mental well-being.
OBJECTIVE:
This study aimed to analyze the urinary metabolome of volunteers who consumed a drink based on Costa Rican blackberries (Rubus adenotrichos) to identify the presence of urolithins and other possible bioactive compounds related to beneficial effects on health.
METHODS:
Fifteen healthy non-smoking male volunteers aged between 19 and 43 years old who consumed 250 ml of blackberry-based drink for breakfast for eight consecutive days were selected. Urine samples were obtained before and after drink consumption, which were submitted to analysis by Ultra-Performance Liquid Chromatography coupled to a Mass Detector (UPLC/ESI-Q-TOF-MS). Subsequently, a metabolomic analysis of the results was performed to identify the presence or absence of urolithins and other bioactive metabolites related to blackberry juice consumption.
RESULTS:
It was possible to detect high intensity presence of urolithin A (n = 6) and high intensity presence of both urolithin A and B (n = 5) in urine samples in several volunteers. However, finding them was impossible in others, or they were at very low intensities (n = 4). Likewise, it was possible to identify Menth-1-en-4,8 diol glucuronide and 1-O-E-Cinnamoyl-(6-arabinosylglucose) as other compounds related to the consumption of blackberries.
CONCLUSIONS:
The consumption of Costa Rican blackberries allowed us to demonstrate the presence of three metabotypes within the study population: 40% of strong urolithin A (UAP) producers, 33.3% of both urolithin (A and B) producers (UBP), and 26.7% of weak urolithin A producers (0P). Finally, it is recommended to carry out more research in this regard, considering a greater number of volunteers and including people of both sexes.
SuQ, ZhaoX, ZhangX, WangY, ZengZ, CuiH, et al.Nano functional food: opportunities, development, and future perspectives. Int J Mol Sci. 2022;24(1):234.
2.
ManachC, HubertJ, LlorachR, ScalbertA. The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol Nutr Food Res. 2009;53(10):1303–15.
3.
EspínJC, González-SarríasA, Tomás-BarberánFA. The gut microbiota: a key factor in the therapeutic effects of (poly) phenols. Biochem Pharmacol. 2017;139:82–93.
4.
KaličaninB, VelimirovićD, NešićI. A study on mineral composition of Aronia melanocarpa as a functional food with potential therapeutic properties. J Food Nutr Res. 2022;61(1).
5.
AdamsLS, SeeramNP, AggarwalBB, TakadaY, SandD, HeberD. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem. 2006;54(3):980–5.
6.
KhanRS, AsgharW, KhalidN, NazirW, FarooqM, AhmedI, et al.Phalsa (Grewia asiatica L) fruit berry a promising functional food ingredient: a comprehensive review. J Berry Res. 2019;9(2):179–93.
7.
Acosta-Montoyaó, VaillantF, CozzanoS, MertzC, PérezAM, CastroMV. Phenolic content and antioxidant capacity of tropical highland blackberry (Rubus adenotrichus Schltdl.) during three edible maturity stages. Food Chem. 2010;119(4):1497–501.
8.
SeeramNP, AdamsLS, ZhangY, LeeR, SandD, ScheullerHS, et al.blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem. 2006;54(25):9329–39.
9.
Núñez-SánchezMá, KarmokarA, González-SarríasA, García-VillalbaR, Tomás-BarberánFA, García-ConesaMT, et al.In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: a new potentiality for ellagitannin metabolites against cancer. Food Chem Toxicol. 2016;92:8–16.
10.
SelmaMV, BeltránD, LunaMC, Romo-VaqueroM, García-VillalbaR, MiraA, et al.Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin a from ellagic acid. Front Microbiol. 2017;8:1521.
11.
Garcia-MuñozC, VaillantF. Metabolic Fate of Ellagitannins: Implications for health, and research perspectives for innovative functional foods. Crit Rev Food Sci Nutr. 2014;54(12):1584–98.
12.
HassanHA, YousefMI. Mitigating effects of antioxidant properties of black berry juice on sodium fluoride induced hepatotoxicity and oxidative stress in rats. Food Chem Toxicol. 2009;47(9):2332–7.
13.
LarrosaM, González-SarríasA, Yáñez-GascónMJ, SelmaMV, Azorín-OrtuñoM, TotiS, et al.Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem. 2010;21(8):717–25.
14.
LandeteJM. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int. 2011;44(5):1150–60.
15.
EspínJC, LarrosaM, García-ConesaMT, Tomás-BarberánF. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: The Evidence So Far. Evid Based Complement Alternat Med. 2013;2013:270418.
16.
BobowskaA, GranicaS, FilipekA, MelzigMF, MoeslingerT, ZentekJ, et al.Comparative studies of urolithins and their phase II metabolites on macrophage and neutrophil functions. Eur J Nutr. 2021;60(4):1957–72.
17.
HuangX, GaoH, JiangX, ZhengZ. Urolithin B, a gut microbiota metabolite, reduced susceptibility to myocardial arrhythmic predisposition after hypoxia. Dis Markers. 2022;2022:6517266.
18.
BingolK. Recent advances in targeted and untargeted metabolomics by NMR and MS/NMR methods. High Throughput. 2018;7(2):9.
19.
Tomás-BarberánFA, González-SarríasA, García-VillalbaR, Núñez-SánchezMA, SelmaMV, García-ConesaMT, et al.Urolithins, the rescue of “old” metabolites to understand a “new” concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol Nutr Food Res. 2017;61(1).
20.
PluskalT, CastilloS, Villar-BrionesA, OrešičM. MZmine modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 2010;11:395.
21.
HuM, KraussM, BrackW, SchulzeT. Optimization of LC-Orbitrap-HRMS acquisition and MZmine 2 data processing for nontarget screening of environmental samples using design of experiments. Anal Bioanal Chem. 2016;408(28):7905–15.
22.
SahaP, YeohBS, SinghR, ChandrasekarB, VemulaPK, HaribabuB, et al.Gut Microbiota conversion of dietary ellagic acid into bioactive phytoceutical urolithin A inhibits heme peroxidases. PLoS One. 2016;11(6):e0156811.
23.
Tomás-BarberánFA, García-VillalbaR, González-SarríasA, SelmaMV, EspínJC. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J Agric Food Chem. 2014;62(28):6535–8.
24.
Romo-VaqueroM, García-VillalbaR, González-SarríasA, BeltránD, Tomás-BarberánFA, EspínJC, et al.Interindividual variability in the human metabolism of ellagic acid: contribution of Gordonibacter to urolithin production. J Funct Foods. 2015;17:785–91.
25.
VaillantF, PérezAM, AcostaO, DornierM. Turbidity of pulpy fruit juice: A key factor for predicting cross-flow microfiltration performance. J Membr Sci. 2008;325(1):404–12.
26.
García-VillalbaR, EspínJC, Tomás-BarberánFA. Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid. J Chromatogr A. 2016;1428:162–75.
27.
Cortés-MartínA, García-VillalbaR, González-SarríasA, Romo-VaqueroM, Loria-KohenV, Ramírez-de-MolinaA, et al.The gut microbiota urolithin metabotypes revisited: the human metabolism of ellagic acid is mainly determined by aging. Food Funct. 2018;9(8):4100–6.
28.
SelmaMV, González-SarríasA, Salas-SalvadóJ, Andrés-LacuevaC, AlasalvarC, ÖremA, et al.The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: comparison between normoweight, overweight-obesity and metabolic syndrome. Clin Nutr. 2018;37(3):897–905.
29.
KorczakM, RoszkowskiP, GranicaS, PiwowarskiJP. Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential. Sci Rep. 2022;12(1):11676.
30.
González-SarríasA, Núñez-SánchezMá, Tomé-CarneiroJ, Tomás-BarberánFA, García-ConesaMT, EspínJC. Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: microRNA cell specific induction of CDKN1A (p21) as a common mechanism involved. Mol Nutr Food Res. 2016;60(4):701–16.
31.
AbdulrahmanAO, AlzubaidiMY, NadeemMS, KhanJA, RatherIA, KhanMI. Effects of urolithins on obesity-associated gut dysbiosis in rats fed on a high-fat diet. Int J Food Sci Nutr. 2021;72(7):923–34.
32.
CerdáB, PeriagoP, EspínJC, Tomás-BarberánFA. Identification of Urolithin a as a Metabolite Produced by Human Colon Microflora from Ellagic Acid and Related Compounds. J Agric Food Chem. 2005;53(14):5571–6.
33.
Tomás-BarberánFA, SelmaMV, EspínJC. Interactions of gut microbiota with dietary polyphenols and consequences to human health. Curr Opin Clin Nutr Metab Care. 2016;19(6):471–6.
34.
García-VillalbaR, BeltránD, EspínJC, SelmaMV, Tomás-BarberánFA. Time course production of urolithins from ellagic acid by human gut microbiota. J Agric Food Chem. 2013;61(37):8797–806.
35.
YangY, RenZZ, WeiWJ, HeZL, DengYL, WangZ, et al.Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma in vitro. Pharm Biol. 2022;60(1):1566–77.
36.
SeeramNP, HenningSM, ZhangY, SuchardM, LiZ, HeberD. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr. 2006;136(10):2481–5.
37.
IshimotoH, ShibataM, MyojinY, ItoH, SugimotoY, TaiA, et al.In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A. Bioorg Med Chem Lett. 2011;21(19):5901–4.
38.
LuC, LiX, GaoZ, SongY, ShenY. Urolithins and intestinal health. Drug Discov Ther. 2022;16(3):105–11.
39.
XiaB, ShiXC, XieBC, ZhuMQ, ChenY, ChuXY, et al.Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice. PLoS Biol. 2020;18(3):e3000688.
40.
González-SarríasA, Giménez-BastidaJA, Núñez-SánchezMá, LarrosaM, García-ConesaMT, Tomás-BarberánFA, et al.Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells. Eur J Nutr. 2014;53(3):853–64.
41.
DaSilvaNA, NaharPP, MaH, EidA, WeiZ, MeschwitzS, et al.Pomegranate ellagitannin-gut microbial-derived metabolites, urolithins, inhibit neuroinflammation in vitro. Nutr Neurosci. 2019;22(3):185–95.
42.
SelmaMV, Romo-VaqueroM, García-VillalbaR, González-SarríasA, Tomás-BarberánFA, EspínJC. The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism. Food Funct. 2016;7(4):1769–74.
43.
AbdelazeemKNM, KaloMZ, Beer-HammerS, LangF. The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs. Sci Rep. 2021;11(1):7117.
44.
WangC, WangZ, XueS, ZhuY, JinJ, RenQ, et al.Urolithin A alleviates neuropathic pain and activates mitophagy. Mol Pain. 2023;19:17448069231190815.
45.
GhoshN, DasA, BiswasN, GnyawaliS, SinghK, GorainM, et al.Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD+ and SIRT1. Sci Rep. 2020;10(1):20184.
46.
TuHJ, SuCJ, PengCS, LinTE, HuangFuWC, HsuKC, et al.Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity. J Food Drug Anal. 2023;31(2):358–70.
47.
HuangWC, LiouCJ, ShenSC, HuS, ChaoJC, HsiaoCY, et al.Urolithin A inactivation of TLR3/TRIF signaling to block the NF-κB/STAT1 axis reduces inflammation and enhances antioxidant defense in poly(I:C)-induced RAW264.7 cells. Int J Mol Sci. 2022;23(9):4697.
48.
AhsanA, ZhengYR, WuXL, TangWD, LiuMR, MaSJ, et al.Urolithin A-activated autophagy but not mitophagy protects against ischemic neuronal injury by inhibiting ER stress in vitro and in vivo. CNS Neurosci Ther. 2019;25(9):976–86.
49.
Cortés-MartínA, García-VillalbaR, González-SarríasA, Romo-VaqueroM, Loria-KohenV, Ramírez-de-MolinaA, et al.The gut microbiota urolithin metabotypes revisited: the human metabolism of ellagic acid is mainly determined by aging. Food Funct. 2018;9(8):4100–4106.
50.
Cortés-MartínA, ColmenarejoG, SelmaMV, EspínJC. Genetic polymorphisms, mediterranean diet and microbiota-associated urolithin metabotypes can predict obesity in childhood-adolescence. Sci Rep. 2020;10(1):7850.
51.
XianW, YangS, DengY, YangY, ChenC, LiW, et al.Distribution of urolithins metabotypes in healthy chinese youth: difference in gut microbiota and predicted metabolic pathways. J Agric Food Chem. 2021;69(44):13055–65.
52.
MeroñoT, PeronG, GargariG, González-DomínguezR, MiñarroA, Vegas-LozanoE, et al.The relevance of urolithins-based metabotyping for assessing the effects of a polyphenol-rich dietary intervention on intestinal permeability: A post-hoc analysis of the MaPLE trial. Food Res Int. 2022;159:111632.
53.
García-MantranaI, CalatayudM, Romo-VaqueroM, EspínJC, SelmaMV, ColladoMC. urolithin metabotypes can determine the modulation of gut microbiota in healthy individuals by tracking walnuts consumption over three days. Nutrients. 2019;11(10):2483.
54.
Iglesias-AguirreCE, García-VillalbaR, BeltránD, Frutos-LisónMD, EspínJC, Tomás-BarberánFA, et al.Gut bacteria involved in ellagic acid metabolism to yield humanurolithin metabotypes revealed. J Agric Food Chem. 2023;71(9):4029–35.
55.
MeretM, BratP, MertzC, LebrunM, GünataZ. Contribution to aroma potential of Andean blackberry (Rubus glaucus Benth.). Food Res Int. 2011;44(1):54–60.
56.
MiyazawaM, HaigouR. Determination of cytochrome P450 enzymes involved in the metabolism of (-)-terpinen-4-ol by human liver microsomes. Xenobiotica. 2011;41(12):1056–62.
57.
HaigouR, MiyazawaM. Metabolism of (+)-terpinen-4-ol by cytochrome p450 enzymes in human liver microsomes. J Oleo Sci. 2012;61(1):35–43.
58.
EmanuelIB, CooperstoneJ, Peduto HandF. UPLC-MS/MS Identification of metabolites in winterberry fruit putatively associated with natural disease resistance to Diaporthe ilicicola. Phytopathology. 2023.
59.
LabhadeS, JainS, ChitlangeS, SharmaS. LC/MS characterization of secondary metabolites of Sphagneticola trilobata J. F Pruski leaves. J Pharm Negat Results. 2023;14(3):1278–83.
